Kirsten I. Taylor

机构：Roche (Switzerland) · ORCID：0000-0002-2480-3137

发表论文 119 篇 · 总被引 5005 次 · h-index 41

代表论文

Trial of Prasinezumab in Early-Stage Parkinson’s Disease (2022 · New England Journal of Medicine · 被引 419)
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease (2024 · Nature Medicine · 被引 128)
Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease (2022 · Scientific Reports · 被引 115)
Self‐Report versus Clinician Examination in Early Parkinson's Disease (2021 · Movement Disorders · 被引 28)
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort (2022 · npj Parkinson s Disease · 被引 19)
Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson’s Disease Motor Progression (2021 · Frontiers in Neuroscience · 被引 18)